Deerfield Management Announces Third Annual XSeed Award to Support Underfunded and Underrepresented NYC Life Science Startups

Cure Membership CTA to Circle Article Body

Cure Membership CTA to Circle Right Rail

The FDA granted a second approval to Syndax’s menin inhibitor Revumenib, expanding its use to a larger genetic subset of acute myeloid leukemia and marking a rare back-to-back win nearly 20 years after the science first emerged.

Thumbnail laboratory pipette test tube research November 2025 - Image

A Targeted Leukemia Drug Just Won Two FDA Approvals in Under a Year

From funding wins to pipeline breakthroughs, these companies are the key players on New York's booming biotech scene.

Template - Cure Best Of

13 Biggest Biotech Companies in New York

Priyanka Jain, CEO and Co-Founder of Evvy, shares how cleanly dividing areas of ownership and expertise among the leadership team, and knowing exactly what not to build, helped the company move from idea to MVP, sell out its first product batch, and raise a $5M seed round.

The One Skill Early Founders Can’t Scale Without: Radical Ownership

FDA's top leadership just announced a fast-track approval pathway for personalized rare-disease therapies, built around clear biologic mechanisms, early patient improvement, and platform-based evidence from just a few treated cases.

FDA Headquarters on the White Oak campus in Silver Spring, Maryland.

FDA Signals New Fast Track for Personalized Rare-Disease Therapies

345 Park Avenue South

Cure by Deerfield Launches Middle East Health Accelerator in Qatar Image

Blue

News & Insights

Your Home in NYC

Cure Founders Pass Membership Benefits 03 Tab Bar Image

Dark Blue

Become a Member

Learn About Our Events

Thumbnail Events Mega Menu Highlight - X Factor Image

Patient Engagement Is the Secret to Smarter Research—Here’s How to Nail It

Meet the 15 Startups Joining Cure’s Middle East Health Accelerator

Your Home in NYC

Cure Events

Learn About Our Events

Accelerating Advances in Health

Deerfield Management Announces Third Annual XSeed Award to Support Underfunded and Underrepresented NYC Life Science Startups

More Stories